Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome

Area of Science:

• Cardiology
• Hematology
• Internal Medicine

Background:

• Idiopathic hypereosinophilic syndrome (HES) is a rare disorder characterized by persistent eosinophilia.
• HES can lead to endocardial damage and valvular dysfunction, resulting in heart failure.
• Endocardiopathy in HES often involves the atrioventricular valves, leading to significant morbidity.

Purpose of the Study:

• To describe the outcomes of atrioventricular valve replacement in patients with HES and associated endocardiopathy.
• To evaluate the efficacy of surgical intervention for intractable congestive heart failure secondary to HES-related valvular dysfunction.

Main Methods:

• Case series describing three patients with idiopathic hypereosinophilic syndrome.
• Patients presented with intractable congestive heart failure due to atrioventricular valvular dysfunction.
• All patients underwent atrioventricular valve replacement surgery.

Main Results:

• Following valve replacement, all three patients experienced significant improvement in exercise tolerance.
• Congestive heart failure symptoms were effectively controlled post-surgery.
• No major perioperative complications were reported in the described cases.

Conclusions:

• Atrioventricular valve replacement appears to be a beneficial therapeutic option for selected patients with HES-related endocardiopathy and heart failure.
• Surgical intervention can restore cardiac function and improve quality of life in this patient population.
• Further research is warranted to establish definitive treatment guidelines for HES-associated cardiac complications.